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Abstract 
 
 
Over the years biopolymer based composites have been replacing synthetic polymer based 
composites for various biomedical applications. This is attributed to the highly biocompatible and 
biodegradable nature of the natural polymers. Several studies have been reported pertaining to 
development of chitosan (CS)/ montmorillonite (MMT) and CS/hydroxyapatite (HA) composites 
for application in bone tissue regeneration. In the present work a CS/MMT/HA composite was 
developed for the fabrication of sintered macrospheric three dimensional (3D) scaffolds. Further 
the composite scaffolds were coated with carboxymethyl tamarind seed powder (CTSP). The 
scaffold fabrication method is based on direct agglomeration of the sintered macrospheres. The 
described method allows fabrication of porous scaffolds with controllable shape and pore size 
distribution. The CS/MMT/HA composite 3D scaffolds were characterized using X-ray diffraction 
(XRD), attenuated total reflectance-Fourier transform infrared (ATR-FTIR) and scanning electron 
microscopy (SEM). The scaffolds were further evaluated for their in vitro bioactivity, 
hemocompatibility, protein adsorption, water adsorption and degradation. The mechanical 
properties were evaluated by analysing the compressive strength. The XRD pattern confirmed the 
presence of the individual components in the composite scaffolds. The ATR-FTIR studies 
confirms the presence of molecular interaction among the various constituents of the composite. 
The SEM micrographs show the pore size and the interconnectivity of the scaffolds. The 
CS/MMT/HA composites show enhanced in vitro biological properties as compared to plain 
chitosan as well as CS/HA and CS/MMT composites. The CS/MMT/HA composite scaffolds 
showed significant improvement in the compressive as compared to the other samples. The present 
work deals with fabrication of chitosan composite scaffolds with well controllable and predictable 
internal architecture and geometry that has potential application in bone tissue engineering. 
 
Keywords: chitosan composite, tamarind seed powder, macrosphere, 3D scaffolds. 
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1. INTRODUCTION 
1.1. Background 
The human body is made up of a number of different tissues and organs which form a 
complex network and have specific individual functions. The aging process of the human 
body brings in a lot of changes which includes loosing or damaging of tissues or their 
functionalities [1]. Orthopaedic injuries are the main area the main area of focus when it 
comes to tissue repair. The major challenge faced by orthopaedic surgeons lies in repairing 
the fractures caused by fractures, tumours, infections, surgery and trauma. Studies have 
shown that every year around 900,000 patients undergo bone replacement surgery. The 
grafts use for these surgeries fall under three categories: autograft, allograft and xenograft 
[2] . When the source of the graft tissue is the same patient it is known as an autograft. It has 
no immunological reactions and therefore high success rates. However it involves the 
complication of double surgeries. Allografts are grafts where the tissue is taken from same 
species. These involve high risk of tissue rejection and disease transmission. When the grafts 
are of animal origin these are known as xenografts. The advantage of xenografts is that these 
are cheap and can be found in bulk but carry a high risk of tissue rejection and bacterial as 
well as viral infections [3]. The properties of different types of different types of grafts which 
help in bone tissue engineering are given in Table 1.1. 
Table 1-1. Types, sources and properties of different bone grafts 
Type of Graft Source Properties 
Autograft Same Patient Osteogenic 
Osteoconductive 
Osteoinductive 
Allograft Same species Osteoinductive 
Osteoconductive 
Xenograft Different species (animal) Osteoconductive 
 
1.2. Tissue Engineering 
The designing and fabrication of these grafts comes under tissue engineering. With the help 
of engineered tissue we can replace and restore various tissue functions by delivering the 
cells obtained from either of the sources to a pre-engineered customized tissue construct for 
implantation. Till now the classical development of two dimensional (2-D) scaffolds have 
been widely used as grafts [4]. However in the body the cells require a three dimensional 
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environment for proliferating and differentiating. Generally the cells are seeded in a 3D 
scaffold that outlines the geometry of the replacement tissue. The fate and function of the 
3D scaffold majorly depends on the cell microenvironment where coordination among the 
temporal, spatial, chemical and mechanical aspects Have a significant part in the graft 
functions. Therefore it can concluded that the selection of materials and design is the first 
and most crucial step in the fabrication of scaffolds [5]. Figure 1.1 shows the graphical 
illustration of the tissue engineering principle. 
 
Figure 1.1. Graphical illustration of Tissue engineering principle 
1.3. Materials for scaffolds 
The material selection process for tissue engineering mainly depends on its biocompatibility, 
hemocomaptibilty, biodegradability, mechanical properties and cell viability. Other 
properties which come into play are the chemical and molecular structure of the material, 
solubility, hydrophobic/hydrophilic nature, water absorption etc. [6]. The material also 
affects the processing and designing of desired morphological structures. A large number of 
materials like polymers, metals and ceramics have been used for scaffold fabrication.  The 
most commonly used metals are steel, cobalt alloys and titanium alloys. As these metals are 
non-degradable they are used for permanent applications like hip implants. Ceramics are 
mostly used for hard tissue engineering like bone and dental implants as they have high 
mechanical strength. Ceramics which commonly used for tissue engineering are alumina, 
zirconia, hydroxyapatite, bioglass etc. However the major disadvantage with ceramics and 
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metals is that these are not only non-biodegradable but also have limited processibility. 
Taking these factors into consideration polymeric materials have garnered significant 
amount of attention in the field of soft tissue engineering like muscle, nerve and skin as they 
can be tailored for the desired scaffold structure [7]. Polymers are of two kinds: natural and 
synthetic. Each type has its specific advantages and disadvantages. In recent years 
development of polymer composite materials for the fabrication of three dimensional 
scaffolds has gained a lot of interest. Both synthetic as well as natural polymers have been 
used for manufacturing such composites. However polymers of natural origin have been 
rapidly substituting the synthetic materials owing to their better biocompatibility and 
biodegradability [8]. 
1.3.1. Chitosan 
Amongst all the various natural polymers available chitosan (CS) is known to have been 
extensively used for numerous biomedical engineering applications. Chitosan is the second 
most abundant polymer avalaible in nature. Chitosan is a polysaccharide derived from chitin 
and consisting of N-acetyl glucosamine and glucosamine linked by β (1-4) linkages where 
around than 60 % acetyl groups are detached via deacetylation [9]. The structure of a 
chitosan molecule is shown in Figure 1.2. 
 
Figure 1.2. Chitosan molecule 
CS has minimal foreign body interaction, excellent osteo-conductivity, suitable degradation 
rate and favourable wettability. It is known to be a homeostatic material with a positive 
influence on wound healing and bone reformation.  Chitosan is structurally similar to 
glycosaminoglycans that are recognised to have a stimulatory effect on matrix organization. 
Owing to this structural similarity chitosan is also believed to have similar effects during 
tissue repair [10]. Several studies have been conducted on the addition of various organic 
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and inorganic materials to chitosan to improve its physicochemical as well as mechanical 
strength. Some of the materials that have been studied as an addition to chitosan to form 
composites hydroxyapatite (HA) and montmorillonite (MMT). The composites formed have 
shown not only good mechanical strength but also improved bioactivity, biodegradability, 
hydrophilicity and anti-bacterial properties. [11]. 
1.3.2. Hydroxyapatite 
Hydroyapatite (HA) is widely used as one of the bioactive ceramic materials due to its close 
structural and compositional resemblance with that of natural bone. HA coatings are not only 
known to enhance the bone bonding ability of the metal surface, but also induce osteo-
conductivity between the implant surface and human tissue in vivo [12]. These metal ions 
are known to cause serious health issues like Alzheimer’s, neuropathy and osteomalacia. HA 
is known to stimulate osteoconductivity and can integrate into natural bone without eliciting 
any immune response. The studies of Kong et al  showed that the scaffolds made from 
CS/HA composite were found to highly porous with enhanced bioactivity, biocompatibility 
and increased rate of cell proliferation compared to that of pure chitosan scaffolds [13]. HA 
is known to be hydrophobic material, its addition to CS reduces its water absorption capacity 
thereby increasing its mechanical strength. Studies have also shown that the CS/HA 
composite scaffolds are well tolerated by the body and are osteoconductive in nature, both 
of which are essential requirements in biomedical application. Pure hydroxyapatite, 
however, is very brittle, and its mere adhesion to metal surface add to its possible limitations 
under shear forces and other loads when coated on metal surfaces [14].The structure of HA 
molecule is shown in Figure 1.3. 
 
Figure 1.3. Hydroxyapatite molecule 
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1.3.3. Montmorillonite 
Monmorillonite is a nanoclay which is a part of the smectite group of minerals. It has a 
layered alumina silicate structure where an octahedral sheet of aluminium hydroxide is 
bonded in between two tetrahedral of silica. The large surface area and high aspect ratio 
makes MMT a suitable filler material. The use of montmorillonite for the fabrication of 
PCNs was discovered by Toyotaa research group when their studies showed significant 
enhancement in mechanical properties of the PCNs with small montmorillonite loadings 
[15]. The investigations have suggested modifier usage to enhance the clay miscibility in the 
polymer. The functional groups and backbone present in the modifier are known to affect 
the d-spacing of the clay. A novel CS/HA/MMT composite with enhanced mechanical 
property and biocompatibility for biomedical applications was reported by Katti et al. 
Studies have sbrought to light that the addition of MMT has significantly improved the 
mechanical properties of polymers. The findings of Xu et al have shown the improved 
mechanical properties of the CS/MMT scaffold. There have been various other studies which 
show the enhanced biological properties of the CS/MMT composite including cell viability 
and proliferation [16].The structure of montmorillonite molecule is shown Figure 1.4. 
 
Figure 1.4. Montmorillonite molecule 
1.3.4. Carboxymethyl tamarind seed powder 
Tamarnd seed powder is obtained from Tamarindus indica and has found potential 
application as a pharmaceutical agent and to form gel. This biopolymer is composed of 1, 4-
d-glucopyranosyl backbone which is partially substituted with 1, 6-d-xylopyranosyl side 
chains, a number of which are thereafter replaced with 1, 2-d-galactopyranosyl residues. 
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This natural form of the polymer however has a number of drawbacks. There the polymer is 
modified by carboxymethylation. The modification improves the polymer solubility in cold 
water and removes bad odour [17]. The structure of tamarind seed powder molecule is shown 
in Figure 1.5. 
 
Figure 1.5. Tamarind seed powder molecule 
1.4. Scaffold designing  
Scaffold design and fabrication is by far the most crucial aspect of tissue engineering and 
regenerative research. Scaffold properties are mostly attributed to variables like pore size, 
microstructure, porosity, mechanical properties and surface chemistry. These above 
mentioned qualities are fulfilled in better way by 3-D scaffolds as compared to 2-D scaffolds. 
The native tissue structure of the extracellular matrix should be well mimicked by the 
scaffold microstructure [18]. The scaffolds should not only be sufficiently porous but should 
also have well interconnected pores for transport of nutrient and wastes. Besides porosity, 
mechanical properties of the scaffold is another major aspect of tissue designing. The 
scaffold should have adequate mechanical strength to resist the various stresses it is 
subjected to along with the physiological loads during tissue regeneration. It is preferred that 
the mechanical properties of the scaffold especially its Young’s modulus should be similar 
to the corresponding tissue it is substituting, in order to avoid stress shielding. The presence 
of different functional groups which are present on the surface of the scaffold is also essential 
for the attachment of various biological molecules. The topography of the scaffold should 
be such that it facilitates the attachment, proliferation and differentiation of the cells. Thus 
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it can be concluded that scaffold design plays an important role in graft implantation [19]. 
Figure 1.6 shows different scaffold properties 
 
Figure 1.6. Schematic representation of scaffold properties 
1.4.1. Macrospheric 3-D scaffolds 
The development of three dimensional (3-D) scaffold based implants have become an 
important technique for bone restoration and regeneration in the field of tissue engineering. 
Bone scaffolds must have high porosity as well good mechanical strength. The 
interconnected pores are important as they are indispensable for cell ingrowth, proliferation 
and nutrient transport in the scaffold [20]. The mechanical properties of the graft should be 
similar to that of the natural bone to prevent stress shielding. However, the scaffolds with 
high porosity tend to have poor mechanical strength. In recent years various methods free 
drying, electrospinning etc. have been explored which provide polymeric scaffolds with high 
porosity. These scaffolds do not possess enough mechanical strength. In order to obtain bone 
scaffolds with both porosity and high mechanical strength we need to optimize both suitable 
biomaterial and the method of fabrication of scaffold. The described method allows 
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fabrication of scaffolds which are porous and have controllable shape and pore size 
distribution [21]. Figure 1.7 shows graphical illustration of the 3-D macrosphere scaffold 
fabrication. 
 
Figure 1.7. Graphical illustration of 3D macrosphere scaffold fabrication 
1.4.2. Curing of the 3-D macrospheric scaffolds 
One of the earliest sintered macrosphere scaffolds (SMSs) were reported in 2001 by Borden 
et al. These SMSs not only aided in controlled release of drugs but also facilitated cell 
proliferation due to their porous structure. It was seen that compared to the traditional 3-D 
scaffolds, SMS significantly enhances the mechanical properties. The compressive strength 
of these scaffolds was found equal to that of the cancellous bone. A graphical illustration of 
SMS preparation is shown in Figure 1.7. Currently there are two different ways to fuse the 
macrospheres together for the fabrication of the scaffolds. The first method involves heating 
of the macropheres which are stacked in a mould, above the glass transition temperature (Tg) 
of for several hours. Thereafter the mould is removed to obtain the desired 3-D scaffolds. 
The second method involves use of a suitable solvent to bond the macrospheres together 
[22], [23]. Figure 1.8 shows the graphical illustration of macrosphere fusing due to sintering. 
 
Figure 1.8. Graphical illustration of macrosphere fusing due to sintering 
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1.5.  Objectives 
In the present work a CS/MMT/HA composite was developed and further used for the 
production of sintered macrospheric 3D scaffolds. Further the composite scaffolds were 
coated with carboxymethyl tamarind seed powder (CTSP).The scaffold fabrication method 
is based on direct agglomeration of the macrospheres. The defined methodology allows 
fabrication of scaffolds which are porous and have controllable shape and pore size 
distribution. The fabricated samples were then subjected to sintering, which is known to 
improve the mechanical properties of the composite. The CS/MMT/HA composite 3D 
scaffolds were characterized using attenuated total reflectance-Fourier transform infrared 
(ATR-FTIR), X-ray diffraction (XRD), and scanning electron microscopy (SEM). The 
scaffolds were further assessed for their in vitro bioactivity, hemocompatibility, protein 
adsorption, water adsorption and degradation. The mechanical properties were evaluated by 
analysing the compressive strength. 
 Solid state synthesis of hydroxyapatite 
 To develop polymer composite (Chitosan /Montmorillonite /Hydroxyapatite/ 
Tamarind seed powder) macrospheric three dimensional scaffolds. 
 To characterize the processed composite scaffolds. 
 To perform in-vitro biological studies. 
 To compare the different variants of the composite scaffolds for their biological and 
mechanical properties. 
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1.6.  Work Plan 
 
 
 
 
 
 
 
 
 
Chapter 2 
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2. LITERATURE REVIEW 
Over the years, a huge advancement in the fields of surgical replacement and organ 
transplantation to treat organ or bone tissue loss. Be that as it may, the deficiencies connected 
with autografting and allografting transplantation, for example, inalienable contributor site 
restrictions, tissue dismissal and infections have led to the advancement of tissue building, 
which recovers new tissue utilizing cells, bioactive atoms and scaffolds. The grafts 
comprising polymers and ceramics materials might have beneficial properties, for example, 
biodegradation, biocompatibility and mechanical strength [24] . 
Polymers which are biodegradable should deteriorate in the body without producing any of 
toxic items in the tissues. Biodegradation of the polymers can be acquired by cutting 
hydrolytically unsteady links in the back bone of the polymer. An insert fabricated from 
polymers which are biodegradable can be built to degrade at a rate that will gradually 
exchange burden to the mending spine. These polymers ought to have: (i) polymers and their 
decay items ought to be evoke any immunogenic response or any lethality; (ii) degradation 
and retention rates ought to be equilibrium with the regeneration of the tissue ; and (iii) 
polymeric materials ought to have magnificent mechanical properties similar to that of the 
human tissues [25]. 
Biocompatibility shows the capacity of materials to accomplish its role with a proper host 
reaction, in a particular application. This incorporates both structural as well as surface 
compatibility. Surface similarity implies the compound, organic, physical (counting surface 
morphology) appropriateness of an insert morphology to the tissue of the host. Auxiliary 
similarity is the ideal adjustment to the mechanical conduct of the tissues of the host. Once 
inserted in the body, the mechanical properties of regular bone change with their organic 
area on the grounds that the crystallinity, porosity and arrangement of bone acclimate to the 
natural and biomechanical situations [26]. The great fracture toughness as well tensile 
strength of bone are credited to the intense and adaptable collagen filaments fortified by 
hydroxyapatite (HA). 
The mechanical power of scaffolds is of great significance in tissue engineering, since they 
are closely related to the stable structure and strength in practical applications. The scaffolds 
are desired to have sufficient mechanical power to work appropriately starting from the 
implantation time to the completion of tissue regeneration process. A number of factors can 
be accounted for the mechanical response of multi-component composite scaffold, like the 
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size of particle of the inorganic components, the intrinsic mechanical properties of the 
organic component, as well as the interactions among the inorganic and organic components, 
the ratio of the inorganic/organic content and character of cross linking [27]. Furthermore, a 
decline in scaffold porosity and rise in pore wall thickness, significantly increase the 
mechanical properties. As the scaffold relies on the pore wall to pass the stress and bear the 
load, the structure of the pores and the pore wall thickness will affect the mechanical 
properties substantially. The scaffold with lesser concentration has the thinner pore wall and 
higher porosity. It was observed that if the porosity was raised and pores were enlarged, it 
resulted in decrease of mechanical strength. 
The scaffold strength is of specific significance in tissue designing, since they are firmly 
connected to the durability and stability of the implant. The scaffolds should have enough 
mechanical quality to work successfully from the time of grafting to the completion of tissue 
regeneration. Numerous elements can add to the mechanical reaction of multi-segment 
composite implant, for example, the molecule size of the inorganic segments, the 
characteristic mechanical properties of the implant material and the interfacial associations 
between the inorganic and natural polymers, the proportion of the inorganic/natural 
substance and cross connecting character [28]. Besides, a decrease in framework porosity 
and an expansion in pore wall thickness, enormously upgrade the mechanical properties. As 
the implant relies upon the pore wall to infuse the applied stress and bear the load, the pore 
structure and the thickness of pore wall will influence the mechanical properties 
considerably. The implant with lower concentration has the thinner pore wall and higher 
porosity. Increasing porosity and growing pores brought about reduction of mechanical 
quality [29]. 
Chitosan and its subsidiaries are exceptionally appealing biomaterials in the scaffold 
composites on account of their tendency to degrade while the new tissue is regenerated, in 
the end without provocative responses or dangerous degradation. Tang et al. demonstrated 
that the common Cs and HA composites have an excellent biocompatibility with the hard 
tissue and an incredible osteoconductivity. They likewise proposed that this composite might 
be appropriate for simulated bone embeds and edge materials of tissue building. Jayabalan 
et al. have reported a nano composite containing calcinated HA particles is both 
biocompatible and osteocompatible. They additionally demonstrated that HA could 
conceivably enhance both the mechanical properties and biocompatibility of bone uniting 
materials. The electro spun nano composite nano filaments of HA/chitosan with their 
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composition and structure close to the common mineralized nanofibril partners were set up 
by Zhaang et al [30]. The report stated that these nano composite filaments are of potential 
use for bone tissue building applications. Kaashiwazaki et al. have created unique CS/HA 
nano composites with permeable structure by the co-precipitation and porogen filtering 
strategy. These composites were discovered to have both enhanced biocompatibility as well 
as biodegradation. Chitosan nano strands with a normal measurement ranging from 100 to 
50 nm were effectively arranged by means of electrospinning of chitosan and poly vinyl 
liquor mix arrangement. A CS/HA nano hybrid implant with high porosity and uniform 
nanostructure had additionally been created through a bionic treatment joined with thermally 
affected phase separation. These nHA particles highly affected coordinating crystallization 
of apatite in the framework and prompted the great bioactivity of the nano cross breed 
platform. Zhaao et al. established a CS/HA–gelatin network (HA/CS-Gel) composite which 
was biodegradable and had a comparative organization to that of ordinary human bone 
readied as a 3D biomimetic platform by stage detachment technique for bone tissue building. 
Zhaao et al. manufactured two sorts of biomimetic composite materials, chitosan–gelatin 
(CG) and hydroxyapatite/chitosan–gelatin (HCG) and showed upgraded protein and calcium 
particle adsorption properties of HA in the CG polymer system which enhanced introductory 
cell-attachment and long term development, support osteogenic separation upon incitement, 
and also kept up the progenicity of the 3D human mesenchymal immature microorganism 
(hMSCs) builds. Liuyuun et al. stated the physicochemical and natural properties of a unique 
biodegradable composite platform made of nano-hydroxyapatite and polymers of chitosan 
and carboxymethylated cellulose, in particular, nHAp/CS/CMC, which was set up by stop 
drying technique. The platform was non-lethal and had great cell biocompatibility, and the 
consequences of implantation investigation in vivo demonstrated that the framework has 
great tissue biocompatibility and has an awesome potential to be utilized as bone tissue 
designing material [31]. 
The major challenge in developing scaffolds with sufficient mechanical properties presents 
a unique difficulty in the field of 3D tissue engineering. The test of creating scaffolds with 
sufficient mechanical properties displays a one of a kind issue in tissue engineering. PCNs 
appear to have colossal potential concerning the part of accomplishing satisfactory 
mechanical properties. The work on the utilization of MMT for the arrangement of PCNs 
was brought to light by the Toyota research group when they stated critical change in 
mechanical properties of the PCNs made out of little MMT loadings. Consequently, MMT 
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was utilized for the arrangement of PCNs in different studies that reported increment in 
mechanical properties, diminish in gas diffusion and combustibility, and impact on 
biodegradability after the expansion of MMT [32]. 
Macrospheres are naturally streaming particles made out of inorganic and/or polymeric 
materials. Ordinarily, macrospheres are utilized as vehicles for controlled discharge since 
they can beat the downsides of ordinary treatment and upgrade the viability of the given 
medication. As of late, because of the fast advancement of tissue designing, macrospheres 
have been utilized as a part of tissue engineered scaffolds. In macrosphere-based/containing 
scaffolds, macrospheres assume an imperative part in both medication discharge and cell 
habitation. There are two sorts of macrospheres chiefly displaying scaffold properties, which 
are macrosphere sintered and macrosphere joined scaffolds. Taken together, the 
improvement of macrosphere-based/containing scaffolds may open another entryway for 
developing medication discharge platforms for bone regenerative applications [33]. 
The development of three dimensional (3D) scaffold based implants have become an 
important method for bone healing and regeneration in the field of tissue engineering. Bone 
scaffolds must have high porosity as well good mechanical strength. The interconnected 
pores are important as they are indispensable for cell ingrowth, proliferation and nutrient 
transport in the scaffold. The mechanical properties should be similar to that of the natural 
bone to prevent stress shielding. However, the scaffolds with high porosity tend to have poor 
mechanical strength. In recent years various methods free drying, electrospinning etc. have 
been explored which provide polymeric scaffolds with high porosity. These scaffolds do not 
possess enough mechanical strength. In order to obtain bone scaffolds with both porosity 
and high mechanical strength we need to optimize both suitable biomaterial and the method 
of fabrication of scaffold. The defined methodology allows fabrication of scaffolds which 
are porous and have controllable shape and distribution of pore size. 
One of the earliest sintered macrosphere scaffolds (SMSs) were reported in 2001 by Borden 
et al. These SMSs not only aided in controlled release of drugs but also facilitated cell 
proliferation due to their porous structure. It was seen that compared to the traditional 3D 
scaffolds, SMS significantly enhances the mechanical properties. The compressive strength 
of these scaffolds was found equal to that of the cancellous bone. A graphical illustration of 
SMS preparation is shown in Figure. Currently there are two different ways to fuse the 
macrospheres together for the fabrication of the scaffolds. The first method involves heating 
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of the macropheres which are stacked in a mould, above the glass transition temperature (Tg) 
of for several hours. Thereafter the mould is removed to obtain the desired 3D scaffolds. The 
second method involves use of a suitable solvent to bond the macrospheres together.  
Three dimensional (3-D) scaffolds are commonly used for drug delivery, investigation of 
cell behaviour and material studies in the field of tissue engineering. Three-dimensional 
scaffolds are typically porous, biocompatible and biodegradable materials that serve to 
provide suitable microenvironments, that is, mechanical support, physical, and biochemical 
stimuli for optimal cell growth and function. The porosity and pore size of 3-D scaffolds 
have direct effects on their use during biomedical applications. Networks which are opwn 
and interconnected are vital for cell nutrition, proliferation, and migration for vascularization 
of tissue and formation of new tissues [34]. A porous surface also serves to facilitate 
mechanical interconnection between the scaffolds and adjoining tissue to improve the 
mechanical stability of the implant. In addition, the network structure of the pores assists in 
guiding and promoting new tissue formation. Materials with high porosity enable effective 
release of biofactors such as proteins, genes, or cells and provide good substrates for nutrient 
exchange. However, the mechanical property that is important in maintaining the structural 
stability of the biomaterial is often compromised as the result of increased porosity. Hence, 
an equilibrium between the mass transport and mechanical function of the scaffolds should 
exist for an ideal scaffold system. As a result, the final porosity and pore sizes of the scaffold 
should be taken into account in accordance to the intended eventual application during 
scaffold design and fabrication stages. This review is focused on the fabrication of porous 
3D scaffolds, the methods for evaluating porosity and pore sizes of 3-D constructs, and some 
of the reported effects of pore size and porosity on cell behaviour and overall mechanical 
properties. A more general overview of the various scaffold fabrication and porosity 
measurement techniques has been covered in previous reviews [35]. 
Three dimensional (3-D) scaffolds are normally utilized for medication conveyance, 
examination of cell conduct and material studies in the field of tissue building. 3-D scaffolds 
are commonly porous, biocompatible and biodegradable materials that serve to give 
appropriate microenvironments, that is, mechanical backing, physical, and biochemical jolts 
for ideal cell development and capacity. The porosity and pore size of 3-D platforms have 
direct effects on their usefulness amid biomedical applications. Open permeable and 
interconnected systems are key for cell sustenance, multiplication, and movement for 
vascularization of tissue and development of new tissues. A permeable surface additionally 
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serves to encourage mechanical interconnection between the platforms and encompassing 
tissue to enhance the mechanical dependability of the insert. What's more, the system 
structure of the pores helps with directing and advancing new tissue development [36]. 
Materials with high porosity empower successful arrival of biofactors, for example, proteins, 
qualities, or cells and give great substrates to supplement trade. Be that as it may, the 
mechanical property that is imperative in keeping up the auxiliary security of the biomaterial 
is regularly traded off as the aftereffect of expanded porosity. Consequently, a harmony 
between the mass transport and mechanical strength of the scaffolds ought to exist for an 
ideal platform framework. Thus, the last porosity and pore sizes of the framework ought to 
be considered in understanding to the planned possible application amid platform 
configuration and manufacture stages. This audit is centred around the creation of permeable 
3-D scaffolds, the strategies for assessing porosity and pore sizes of 3-D builds, and a portion 
of the reported impacts of pore size and porosity on cell conduct and general mechanical 
properties. A broader outline of the different scaffold manufacture and porosity estimation 
methods has been secured in past surveys [37]. 
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3. MATERIALS AND METHODS 
3.1. Materials 
3.1.1. Hydroxyapatite synthesis by ammoniacal precipitation 
HA was synthesized by ammoniacal precipitation method, with a constant Ca/P ratio of 1.67. 
In the solid state synthesis of HA diammonium phosphate ((NH4)2HPO4) and calcium nitrate 
tetra hydrate (Ca (NO3)2.4H2O) were used as predecessors of phosphate and calcium, 
respectively. NaHCO3 as a gas foaming agent. A mortar pestle was used for grounding and 
blending the reactants. The blended reactants were then kept for aging for about 24 h. The 
by-products were removed by washing the reactants a number of times with ethanol and 
deionized water. The washed reactants were kept in a hot air oven at 80 °C for 6 h and then 
calcinated for 1 h at 650 °C for obtaining HA.        
3.1.2. Preparation of chitosan macrospheres 
The biopolymer solution was prepared by dissolving chitosan (2 w/v %) in an aqueous 
solution of glacial acetic acid (2 v/v %). The polymer solution was then added drop wise 
through a capillary into a gently stirring coagulation solution (1 N sodium hydroxide and 26 
v/v % ethanol). The coagulated macrospheres were then filtered and washed multiple times 
with distilled water to obtain neutrality. Similarly macrospheres were also prepared with the 
respective chitosan composite solutions [38]. The three variations of chitosan composite 
solutions prepared were: CS/HA, CS/MMT and CS/HA/MMT. The CS/MMT and CS/HA 
composite solutions were prepared by dissolving 10 w/w % of MMT and HA in the solution 
of pure CS respectively. The CS/MMT/HA composite was prepared by dissolving 10 w/w% 
[39]. In order to prepare the CS composite solutions the corresponding reinforcements were 
added to the pure biopolymer solutions and stirred overnight until a homogenous solution 
was obtained. 
3.1.3.  Preparation of uncoated chitosan composite 3D macrospheric scaffolds  
The filtered and neutralized macrospheres were vacuum dried for 24 h before being used for 
3-D scaffold fabrication. The vacuum dried macrospheres were then moulded with the help 
of a cylindrical plastic mould. The mould can be of any desired dimensions. After the 
macropspheres were stacked in the mould it is washed with 2 ml solution of glacial acetic 
acid (1 v/v %) for 60 s. The scaffold is then compressed with the back of the plunger of a 
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syringe. This was followed by washing with 5 % NaOH solution for 60 s. The acetic acid 
was causes the outer layer of the macrospheres to dissolve which leads to joining of the 
adjacent macrospheres under the compression of the plunger. The NaOH wash assures that 
the macrospheres do not dissolve completely under the effect of the acetic acid by 
neutralizing the acid. The scaffold is then removed from the mould and incubated in a water 
bath at for 24 h at 37 °C.  
3.1.4. Preparation of CTSP coated chitosan composite 3-D macrospheric scaffolds 
The CTSP solution was prepared by dissolving 5 w/v % CTSP in distilled water and stirring 
the solution overnight until a homogenous solution is obtained. The filtered and neutralized 
macrospheres were vacuum dried for 24 h before being used for 3-D scaffold fabrication. 
The vacuum dried macrospheres were then moulded with the help of a cylindrical plastic 
mould. The mould can be of any desired dimensions. After the macropspheres were stacked 
in the mould it is washed with 2 ml solution of glacial acetic acid (1 v/v %) for 60 s. The 
scaffold is then compressed with the back of the plunger of a syringe. This was followed by 
washing with 5 % NaOH solution for 60 s. The acetic acid was causes the outer layer of the 
macrospheres to dissolve which leads to joining of the adjacent macrospheres under the 
compression of the plunger. The NaOH wash assures that the macrospheres do not dissolve 
completely under the effect of the acetic acid by neutralizing the acid. The scaffolds were 
then dipped in the CTSP solution for 24 h. 
3.1.5. Sintering of coated and uncoated chitosan composite 3D scaffolds  
The final step of chitosan composite 3-D scaffold fabrication comprises of sintering. The 
samples were kept on glass slide and covered with a glass beaker to create a controlled 
environment for sintering. The said set up also insures that there is not loss of moisture 
during the sintering process. The scaffolds were sintered at 140 °C, which is the glass 
transition temperature of chitosan for 1 h. The sintering process increase. The sintering 
process is known to enhance the surface bonding of the macrospheres and also increase the 
mechanical strength of chitosan. The sintered chitosan composite scaffolds were then stored 
in a vacuum desiccator for future use. The entire process of scaffold preparation is shown in 
Figure 3.1. The composition of various chitosan composite scaffolds along with their 
respective codes is given in Table 3.1. 
Table 3.1. Composition of CS composite scaffolds with their respective codes 
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Serial 
No. 
Sample Composition Sample 
Code 
1. Uncoated Chitosan (2 wt/v %) CS 
2. Uncoated Chitosan/Montmorillonite (2 wt/v % and 10 wt/wt %) CSM 
3. Uncoated Chitosan/Hydroxyappatite (2 wt/v% and 10 wt/wt %) CSH 
4. Uncoated Chitosan/Montmorillonite/Hydroxyappatite (2 wt/v % 
and 10 wt/wt %) 
CSHM 
5. CTSP Coated Chitosan (2 wt/v %) CS’ 
6. CTSP Coated Chitosan/Montmorillonite (2 wt/v% and 10 wt/wt 
%) 
CSM’ 
7. CTSP Coated Chitosan/Hydroxyappatite (2 wt/v% and 10 wt/wt 
%) 
CSH’ 
8. CTSP Uncoated Chitosan/Montmorillonite/Hydroxyappatite (2 
wt/v % and 10 wt/wt %) 
CSHM’ 
 
 
Figure 3.1. Methodology of macrospheric scaffold fabrication 
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3.1.6. X-ray diffraction analysis (XRD) 
The XRD graphs of chitosan composite scaffolds (CS, CSM, CSH, CSMH, CS’, CSM’, 
CSH’ and CSHM’) were obtained to investigate phase content of composite scaffolds for a 
scanning range of 2θ =5-60º. The readings were taken at a scanning rate of 5º /min having 
step size of 0.05º, using Rigaku Ultima IV diffractometer (Japan) with Cu Kα radiation 
(λ=1.5418 Å), operating at 40 kV. 
3.1.7. Scanning electron microscopy (SEM) 
The morphology of the surface and size of pores of the prepared chitosan composite were 
examined using the SEM (JOEL JSM 6480LV, USA). Prior to analysis, samples were cut 
into very thin slices with a razor blade and coated with gold using a sputter coater and then 
samples were analysed at 15 kV. 
3.1.8. Attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-
FTIR) 
ATR-FTIR spectra of the chitosan composite scaffolds was attained using the Bruker, Alpha 
E spectrophotometer (Germany). The transmittance spectra was obtained in the range of 
4000–520 cm−1 at a spectral resolution of 4 cm−1. The ATR-FTIR spectra gives a clear 
picture about the molecular interaction between the individual constituents of the chitosan 
composite. 
3.1.9. Protein adsorption study 
The adsorption of protein on the surface of the composite scaffolds was studied by using 
BSA as the standard protein solution and Bradford assay to quantify the amount of protein 
adsorbed. The BSA solution was prepared in phosphate buffer saline (PBS). The samples 
were cut in equal sizes (1 cm × 1 cm) and dipped in BSA (1 mg/ml BSA in PBS) solution 
for 24 h at 37 °C. After were then centrifuged at 4000 rpm for 10 minutes. The quantification 
of the protein adsorbed was done by a 100 μl aliquot of the non-adsorbed protein solution 
mixed with 1 ml of Bradford reagent and 2 ml of distilled water. The concentration of 
adsorbed protein was analysed by UV spectrophotometer measurement at 595 nm using a 
previously calibrated plot. In order to accurately determine variations in the concentration 
of adsorbed protein on the different composite scaffolds the readings were taken in triplicates 
for each sample. 
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3.1.10. Hemocompatibility studies 
In order to determine whether the chitosan composite scaffolds are compatible with the 
microenvironment of the body it is essential to perform the hemocompatibility test. Prior to 
the test the samples were immersed in 10 ml of physiological saline for 24 h. The test was 
performed with goat blood mixed with trisodium citrate and diluted upto 0.8 v/v % with 
physiological saline. The samples were immersed in 0.5 ml of the diluted goat blood for 1 h 
at 37 °C. After incubation the samples were centrifuged at 6000 rpm for 10 minutes. The 
physiological saline was used as the negative control whereas a solution of 0.5 ml of blood 
added into 10 ml of 0.01N HCl was used as the positive control. The absorbance (OD) was 
recorded at 545 nm [40]. The hemolysis percentage (%) was calculated using the following 
equation  
                                  % Haemolysis =(
𝑂𝐷𝑡𝑒𝑠𝑡  − 𝑂𝐷−𝑣𝑒
𝑂𝐷+𝑣𝑒−𝑂𝐷−𝑣𝑒
) 𝑋100                              (1) 
3.1.11. Water absorption study 
The swelling capacity of the chitosan composite scaffolds was determined in phosphate 
buffer saline (PBS). The scaffolds were cut into pieces of equal size (1 cm × 1 cm) and their 
dry weight was measured. The scaffolds were then immersed in 10 ml PBS at room 
temperature. The scaffolds were taken out at an interval of 1 h, the surface was dried and the 
samples were weighed to determine the wet weight of the samples. The procedure was 
repeated till the scaffolds showed almost constant weight [41]. The swelling percentage (Sw 
%) was calculated using the following equation    
                                               𝑆𝑤(%) = [
𝑊𝑤− 𝑊𝑑
𝑊𝑤
] 𝑋 100%                                       (2)       
where Ww  is the wet weight of the sample whereas the Wd  is the dry original weight of the 
sample. 
3.1.12. Degradation studies 
The in vitro degradation of chitosan composite scaffolds was evaluated by soaking the 
samples in PBS solution and the degradation percentage was calculated for 2, 4 and 6 weeks 
respectively. The scaffolds were cut into pieces of equal sizes (1 cm × 1 cm) and weighed. 
The samples were then soaked in 10 ml PBS and maintained at a constant temperature of 37 
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°C. The PBS solution was not replaced during the experiment so that the change in pH at the 
end of the second, fourth and sixth week can be recorded. At the end of the respective weeks 
the scaffolds were taken out and the pH of the PBS was measured. The scaffolds were 
washed with water and dried at 40 °C for 4 days. After drying the final weight of the scaffolds 
was recorded [42]. The degradation percentage (Dw) was calculated using the following 
equation where Wi and Wf   are the initial and final weights of the chitosan composite 
scaffolds respectively.  
                                                       𝐷𝑤 = [
𝑊𝑖− 𝑊𝑓
𝑊𝑖
] 𝑋 100%     (3)                                                                                            
3.1.13. In vitro bioactivity studies 
The chitosan composite scaffolds were analysed for the apatite formation on the surface of 
the scaffolds after soaking them in simulating body fluid (SBF) for 3 weeks. The SBF was 
prepared according to the protocol proposed by Kokubo and Takadama. The scaffolds were 
cut into pieces of equal sizes and soaked in SBF solution at a constant temperature of 37 °C. 
At the end of 3 weeks the scaffolds were then taken out, rinsed with distilled water and dried 
for 12 h at 37 °C. The scaffolds were then observed under SEM to evaluate the morphology 
of apatite formed on the chitosan composite scaffolds [43]. 
3.1.14. Mechanical studies 
The mechanical properties of the chitosan composite scaffolds were evaluated by 
determining their compressive strength and Youngs modulus. The compressive strength was 
evaluated using the Tinius Olsen H10KS “Universal Testing Machine” as per ASTM 
D6641/D6641M-14  The scaffolds were fabricated with dimensions in the ration 2:1 (height: 
diameter). A load cell of 100 N was used with a constant rate of 1 mm/s and the scaffolds 
were compressed till 70 % deformation.  
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4. RESULTS AND DISCUSSION 
4.1. Scanning electron microscopy 
 
Figure 4.1. SEM micrographs of CS scaffolds 
The present method of scaffold fabrication ensures an open pore structure of the scaffolds. 
The shape of the fabricated scaffolds and diameter of the macrospheres can be altered by 
varying the shape of the mould and diameter of the syringe respectively. In this study same 
size of syringe is used for the fabrication of the various chitosan composite macrospheres 
hence they have same size which is approximately 1 mm. Figure 4.1 shows the SEM 
micrographs of the chitosan composite scaffolds. In Figure 4.1 (a) a strong union between 
the adjacent macrospheres was observed. This strong union was obtained by the acetic acid 
treatment which caused the surface to dissolve partially. Figure 4.1 (b) shows a single 
macrosphere with rough surface. The roughness is caused due to vacuum drying the scaffold 
which lead to loss of considerable amount of water from individual chitosan composite 
macrosphere.  It was observed that the effect of drying was seen mostly on the pure chitosan 
macrospheres. The CSHM composites showed least shrinkage. This can be attributed to the 
water retaining capacity of MMT. It was further observed that the CTSP coating also 
controlled the extent of shrinkage in the chitosan composite macrosphereic scaffolds. Thus 
the CSHM’ composite scaffold minimum shrinkage among all the variants and retained the 
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spherical morphology even after being subjected to vacuum drying. This is a very important 
attribute as this will ensure that the scaffolds retain the desired shape and size. The average 
pore size of the scaffolds was found to be around 700 µm as shown in Figure 4.1 (c). The 
size of an individual macrosphere is shown in Figure 4.1 (d) which is around 1 mm. Thus 
the SEM micrographs confirm the open pore structure of the chitosan composite scaffolds 
and gives an insight into the pore size, macrophere size and surface roughness of the various 
chitosan composite scaffolds. 
4.2. X-ray diffraction analysis 
 
           Figure 4.2. XRD pattern of uncoated CS/HA/MMT composite scaffold 
 
 
         Figure 4.3. XRD pattern of CTSP coated CS/MMT/HA composite scaffolds 
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The XRD patterns were analysed to evaluate the structural phases in the composite scaffolds.  
The XRD peaks of the chitosan composite scaffolds are reported in Figure 4.2 and Figure 
4.3. The principal peaks of HA appeared at values of 25.9º and 32.1º. Previous literatures 
have reported that in pure chitosan, there are two characteristics peaks, one at 2θ=20.02º and 
another one at 2θ=10.53º. In pure chitosan as well as the CS composite scaffolds, the 
diffraction peak at 2θ=20.02º not only gets shifted to 22.8º but also merges with other peaks, 
thereby creating an amorphous peak. Thus, it can be concluded that CS is present in 
amorphous form. This amorphous form can be attributed to the acetic acid and chitosan 
interaction. This interaction acts as a hindrance in inter- and intramolecular hydrogen bond 
formation in CS, leading to a loosely packed structure. The peak for pure MMT is found at 
2θ=6.9º. The characteristics peaks of the individual components are present in the CS 
composite scaffolds as well. The characteristic peak of CTSP is known to be found at 2θ= 
20°. This peak is merged with the amorphous peak of CS.  
4.3. Attenuated total reflectance-Fourier transform infrared spectroscopy 
 
Figure 4.4. ATR-FTIR pattern of CS composite scaffolds 
Attenuated Total Reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) offers 
definite information about chemical bonds and molecular structures of the individual 
components present in the composite. The ATR-FTIR spectra of the CS composite scaffolds 
(CS, CSM, CSMH, CS’, CSM’, CSH’ and CSMH’) are shown in Figure 4.4. In the ATR-
FTIR spectrum of MMT, the bands at 527 and 1031 cm-1 were assigned to Si–O–Al 
deformation and Si–O stretching, respectively. The low intense peak consistent to OH 
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bending of H2O was observed at 1639 cm
-1. The band related to structural OH stretching was 
observed at 3624 cm-1. Moreover, the bands related with OH bending of water and structural 
OH stretching was shifted to 1655 cm-1 and 3626 cm-1, respectively. The ATR-FTIR spectra 
of HA showed the peaks associated to stretching modes of PO4
3- were detected at 1043 and 
962 cm-1.  The bands between 602–567 cm-1 were assigned to bending vibrations of 
phosphate groups present in HA.  The bands at 3570 and 630 cm-1 were related to the 
stretching and liberation modes of OH, respectively. Also, low intense peak of adsorbed 
water (stretching) was present at 1642 cm-1.    
4.4. Protein adsorption studies 
 
Figure 4.5. Protein adsorption graph of CS composite scaffolds 
When a scaffold is implanted in the body it comes in contact with the micro environment of 
the body. The different proteins present in the physiological fluids are one of the major 
components that not only come in contact but also get adsorbed on the surface of the 
scaffolds. These adsorbed proteins mediate various biological responses and further help in 
attachment, growth and proliferation of cells on the scaffold surface. The adsorption of 
proteins is majorly influenced by the surface characteristics like charge, roughness, 
wettability and most importantly the chemistry of the surface. BSA is a glycoprotein which 
is structurally and functionally similar to that of human serum albumin and thus it was used 
to evaluate protein adsorption on the CS composite scaffolds. The protein adsorption studies 
helped us to understand the effect of different reinforcements on protein adsorption ability 
of the CS composite scaffolds. Current studies have showed that the presence of functional 
groups (oxygen, nitrogen, carboxyl, and hydroxyl) on the surface influence protein 
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adsorption. The results showed an increase in protein adsorption in the order 
CSM<CS<CSH<CSMH. The electrostatic force and the hydrophobic interaction are 
important to induce greater protein–surface affinity. The protein adsorption is shown in 
Figure 4.5. It is also seen that the coated variations of the same composites showed higher 
protein adsorption. This can be credited to the surface charge present in the CTSP molecules. 
Among the CTSP coated samples the protein adsorption was found in the order 
CSM’<CS’<CSH’<CSMH’.  
4.5. Hemocompatibility studies 
        
Figure 4.6. Percentage hemolysis of CS composite scaffold 
The interactions between the numerous cellular components and the scaffolds inside the host 
body may lead to cell damage. The interactions can cause rupture of the erythrocytes which 
can be fatal for the body.  Thus the in vitro interaction between the scaffold and blood is 
evaluated to predict the hemcompatibility of the scaffold in vivo. The positive and negative 
control showed 100 % and 0 % hemolysis respectively. The evaluation of the uncoated 
samples showed that the maximum hemolysis was found in pure CS scaffolds which was 
around 1.6 %. The minimum hemolysis was found in CSHM composite which was around 
0.1 %.Thus it is seen that the addition of reinforcements like MMT and HA has reduced the 
haemolysis percentage thereby improving the biocompatibility of the samples. This can be 
due to the hydrophobic nature of both the ceramics used Further when the CTSP coated 
variants of the respective composite scaffolds were evaluated it was seen that the coating 
had significantly reduced the haemolytic nature of the scaffolds. The minimum hemolysis 
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was found in the CSHM’ sample. It must be noted that even though there were variations in 
the haemolytic nature of the various composite scaffolds all the samples are considered 
hemocompatible as all the variants show > 5 % hemolysis. The haemolysis percentage 
profile of the composites is given in Figure 4.6. 
4.6. Swelling studies 
 
Figure 4.7. Swelling percentage of various CS composite scaffolds 
When the scaffolds come in contact with the various physiological fluids of the body they 
have tendency to swell. This swelling tendency can affect the shape and mechanical stability 
of the scaffolds over the extended period of time. The swelling of scaffolds facilitates the 
cells in filtration into the scaffolds in a three dimensional fashion, during cell culture by 
increasing the pore size. However if there is an uncontrolled swelling it can reduce the 
mechanical strength thereby rendering it incompatible for bone tissue scaffolds. CS is known 
for its very high percentage of swelling which is one of the major drawbacks of the polymer 
especially in case of load bearing scaffolds. Thus the swelling profile of the different 
composite scaffolds was compared to analyse the effect of the various reinforcements on the 
swelling behaviour of the scaffolds. The swelling percentage profile of the various uncoated 
samples showed the effect of sintering on the CS composite scaffolds. It was seen that the 
sintering of the scaffolds at the glass transition temperature led to decrease in the swelling 
percentage. Further the reinforcement of CS with MMT and HA also decreased the swelling 
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percentage. The coating of the CS composite scaffolds with CTSP however increased the 
swelling percentage of the sintered composite scaffolds. The maximum swelling was seen 
in the CS’ scaffold and the least was seen in the CSHM scaffold. . According to the results, 
addition of HA and MMT can affect the swelling of the CS composites. The addition of HA 
has induced a reduction in the swelling of the polymer matrix due to formation of a 
momentary HA barricade preventing water infusing into the scaffold. The addition of HA 
reduces the hydrophilicity of the chitosan by joining to the hydrophilic –COOH and –NH2. 
Reinforcement of MMT also played a role in reduction of swelling. The nanosized sheets of 
MMT have formed a block that prevents the interaction between polymer and water 
molecules, leading into reduction of water content in both CSM and CSMH composite 
scaffolds. Therefore, the swelling behaviour of CS based composite scaffolds can be tailored 
by using proper amount of inorganic phase. Further it was seen that the coating of the 
composite samples with CTSP has increased the swelling of the polymer matrix. This is due 
to hydrophilic CTSP molecule coats the entire surface of the composite scaffolds. Figure 4.7 
shows the swelling percentage of the various CS composite scaffolds. 
4.7. Degradation studies 
 
Figure 4.8. Degradation percentage of CS composite scaffolds 
While engineering a new scaffold for bone tissue implantation the degradation rate of the 
scaffold plays a very important role. For bone tissue regeneration stable scaffolds which can 
 Chapter 4                                                                                         Results and Discussion 
36 
 
form equilibrium with the regeneration of bones are required. Chitosan is known for its very 
high rate of biodegradation. Although the degradation products are not harmful to the body 
as the polymer is a naturally occurring one but the high rate of degradation has adverse 
effects on the stability and longevity of the scaffold. Thus the in vitro biodegradation of the 
chitosan composite scaffolds was studied to analyse the effect of the reinforcements on the 
degradation rate of the scaffolds. It was observed that the CS/HA/MMT scaffold which was 
coated with CTSP showed the least rate of biodegradation. The reinforcement of HA and 
MMT individually also affected the biodegradation rate. Figure 4.8 shows the degradation 
profile of the various CS scaffolds for two, four and six weeks. 
4.8. In- vitro bioactivity studies 
The ability of the scaffold to bond directly with the living bone by forming bone like apatite 
on its surface is known as bioactivity of the implant. In the present work the bioactivity of 
the CS composite scaffolds was evaluated by immersing them for 21 days in SBF. After that 
the samples were dried and observed under SEM for evaluating the apatite formation. It is 
known that pure CS has very poor bioactive properties. CS lacks active sites on its surface 
which act as trigger for apatite formation.  The addition of reinforcements especially HA 
enhance the bioactivity of the composite. This is due to the presence of chelating agents in 
the form of Ca2+ and PO4
3- which acts as active sites. MMT and CTSP are also known to 
increase the bioactivity of the composite. In Figure 4.9 and 4.10 the SEM micrographs 
showing the apatite formation on the various uncoated and CTSP coated CS composites is 
shown. It is seen that hardly any apatite formation on the pure CS scaffolds. The CTSP 
coated sample however shows considerable amount of apatite formation when compared to 
pure CS scaffolds. In the other variants we have found high amount of cylindrical apatite 
formation. The CTSP coated scaffolds were found to be more bioactive than their respective 
uncoated variants. The highest bioactivity was found in the CS/HA/MMT CTSP coated 
sample. Thus it can be concluded that the reinforcement of HA and MMT as well as the 
CTSP coating has increased the bioactive nature of the composite scaffolds to a great extent. 
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Figure 4.9. SEM micrographs showing apatite formation in (a) CS (b) CSH (c) CSH             
(d) CSHM  
 
Figure 4.10. SEM micrographs showing apatite formation on CTSP coated (a) CS (b) CSH  
(c) CSM (d) CSHM composites 
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4.9.  Mechanical studies 
      
Figure 4.11. Compressive strength of CS composite scaffolds 
The scaffolds must have enough mechanical strength to resist stress incurred by newly 
formed in vitro till its implantation in vivo. The main aim of this study was to determine the 
increase in compressive strength of the composite scaffolds. There are various factors which 
play an important role in affecting the strength of the scaffolds. The composites of natural 
polymers and ceramics is known to possess more strength than the individual constituents. 
Similarly the addition of nano clay can also alter the compressive strength of the scaffolds. 
Further the sintering of the polymer at its glass transition temperature is known to alter the 
mechanical properties of the polymer. Thus the mechanical strength of the various composite 
scaffold was evaluated to assess the effect of the various factors.  It was detected that there 
was substantial rise in the compressive strength of the CTSP coated samples as compared to 
their corresponding uncoated samples. Thus it can be seen that the coating has significantly 
increased the compressive strength of the samples. The compressive is found to increase in 
the order CS<CSH<CSM<CSHM. This order is found for both coated as well as uncoated 
samples. The mechanical strengths of the various CS composite scaffolds is given in Figure 
4.11.         
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5. CONCLUSION 
In the present study novel macrosphere-based CS/MMT/HA composite scaffolds coated 
with carboxymethyl tamarind seed powder have been fabricated which have enhanced 
mechanical properties for load bearing bone tissue engineering applications. X-ray 
diffraction, scanning electron microscopy, Fourier transform infrared spectroscopy and 
Optical Microscopy were performed to characterize the scaffolds. Among in vitro studies 
protein adsorption, haemolysis and water absorption studies were performed was performed. 
The X-ray diffraction studies showed the various characteristic peaks whereas the SEM 
studies showed surface morphology, pore size and bead size of the composite scaffolds. The 
various functional groups corresponding to the individual components like CS, MMT, HA 
and CTSP were identified through ATR-FTIR. Protein adsorption studies showed an 
increase in protein adsorption in the CSM<CS<CSH<CSMH and further increase in 
adsorption of protein in their CTSP coated variants. The hemocompatibilty test showed that 
although all the samples were sufficiently hemocompatible the CTSP coating further 
enhanced the hemocompatible nature of the composites. The water absorption property of 
the composites was also enhanced by the coating. The work concludes CSMH’ scaffolds 
fabricated with well controllable and predictable internal architecture and geometry has 
potential application in bone tissue engineering. 
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